These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35902389)

  • 21. Wheezing illness caused by respiratory syncytial virus and other agents.
    Yasuno T; Shimizu T; Maeda Y; Yamasaki A; Amaya E; Kawakatsu H
    Pediatr Int; 2008 Aug; 50(4):500-5. PubMed ID: 18937754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent wheezing after respiratory syncytial virus or non-respiratory syncytial virus bronchiolitis in infancy: a 3-year follow-up.
    Valkonen H; Waris M; Ruohola A; Ruuskanen O; Heikkinen T
    Allergy; 2009 Sep; 64(9):1359-65. PubMed ID: 19416146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus: host genetic susceptibility and factors associated with disease severity in a cohort of pediatric patients.
    I G Giamberardino H; O Pacheco AP; Pereira LA; Debur MDC; Genehold G; Raboni SM
    J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36323460
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics and viral load of respiratory syncytial virus and human metapneumovirus in children hospitaled for acute lower respiratory tract infection.
    Yan XL; Li YN; Tang YJ; Xie ZP; Gao HC; Yang XM; Li YM; Liu LJ; Duan ZJ
    J Med Virol; 2017 Apr; 89(4):589-597. PubMed ID: 27632796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and epidemiologic features of respiratory syncytial virus.
    Hall CB; Simőes EA; Anderson LJ
    Curr Top Microbiol Immunol; 2013; 372():39-57. PubMed ID: 24362683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of wheezing after respiratory syncytial virus infection on health-related quality of life.
    Bont L; Steijn M; van Aalderen WM; Kimpen JL
    Pediatr Infect Dis J; 2004 May; 23(5):414-7. PubMed ID: 15131463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
    McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
    J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Respiratory syncytial virus (RSV) immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections: Respiratory Syncytial Virus Immune Globulin Study Group.
    Rodriguez WJ; Gruber WC; Welliver RC; Groothuis JR; Simoes EA; Meissner HC; Hemming VG; Hall CB; Lepow ML; Rosas AJ; Robertsen C; Kramer AA
    Pediatrics; 1997 Mar; 99(3):454-61. PubMed ID: 9041304
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of respiratory pathogens in infants hospitalized for a first episode of wheezing and their impact on recurrences.
    Bosis S; Esposito S; Niesters HG; Zuccotti GV; Marseglia G; Lanari M; Zuin G; Pelucchi C; Osterhaus AD; Principi N
    Clin Microbiol Infect; 2008 Jul; 14(7):677-84. PubMed ID: 18558940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does respiratory syncytial virus subtype influences the severity of acute bronchiolitis in hospitalized infants?
    Papadopoulos NG; Gourgiotis D; Javadyan A; Bossios A; Kallergi K; Psarras S; Tsolia MN; Kafetzis D
    Respir Med; 2004 Sep; 98(9):879-82. PubMed ID: 15338801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of clinical features of acute lower respiratory tract infections in infants with RSV/HRV infection, and incidences of subsequent wheezing or asthma in childhood.
    Ding Q; Xu L; Zhu Y; Xu B; Chen X; Duan Y; Xie Z; Shen K
    BMC Infect Dis; 2020 May; 20(1):387. PubMed ID: 32473625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Substantial Burden of Nonmedically Attended RSV Infection in Healthy-Term Infants: An International Prospective Birth Cohort Study.
    Hak SF; Venekamp RP; Billard MN; van Houten MA; Pollard AJ; Heikkinen T; Cunningham S; Millar M; Martinón-Torres F; Dacosta-Urbieta A; Bont LJ; Wildenbeest JG;
    J Infect Dis; 2024 Mar; 229(Supplement_1):S40-S50. PubMed ID: 38424744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.
    San-Juan-Vergara H; Peeples ME
    Immunol Allergy Clin North Am; 2019 Aug; 39(3):321-334. PubMed ID: 31284923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healthcare costs within a year of respiratory syncytial virus among Medicaid infants.
    Palmer L; Hall CB; Katkin JP; Shi N; Masaquel AS; McLaurin KK; Mahadevia PJ
    Pediatr Pulmonol; 2010 Aug; 45(8):772-81. PubMed ID: 20632403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Respiratory Syncytial Virus and Other Viral Infections among Children under Two Years Old in Southern Vietnam 2009-2010: Clinical Characteristics and Disease Severity.
    Do LA; Bryant JE; Tran AT; Nguyen BH; Tran TT; Tran QH; Vo QB; Tran Dac NA; Trinh HN; Nguyen TT; Le Binh BT; Le K; Nguyen MT; Thai QT; Vo TV; Ngo NQ; Dang TK; Cao NH; Tran TV; Ho LV; Farrar J; de Jong M; van Doorn HR
    PLoS One; 2016; 11(8):e0160606. PubMed ID: 27500954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study.
    Henderson J; Hilliard TN; Sherriff A; Stalker D; Al Shammari N; Thomas HM
    Pediatr Allergy Immunol; 2005 Aug; 16(5):386-92. PubMed ID: 16101930
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Respiratory Syncytial Virus Disease Severity in Young Children.
    Haddadin Z; Beveridge S; Fernandez K; Rankin DA; Probst V; Spieker AJ; Markus TM; Stewart LS; Schaffner W; Lindegren ML; Halasa N
    Clin Infect Dis; 2021 Dec; 73(11):e4384-e4391. PubMed ID: 33095882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children With Respiratory Syncytial Virus Infection.
    Brenes-Chacon H; Garcia-Mauriño C; Moore-Clingenpeel M; Mertz S; Ye F; Cohen DM; Ramilo O; Mejias A
    Pediatr Infect Dis J; 2021 Feb; 40(2):116-122. PubMed ID: 33433159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age-specific incidence rates and risk factors for respiratory syncytial virus-associated lower respiratory tract illness in cohort children under 5 years old in the Philippines.
    Ueno F; Tamaki R; Saito M; Okamoto M; Saito-Obata M; Kamigaki T; Suzuki A; Segubre-Mercado E; Aloyon HD; Tallo V; Lupisan SP; Oshitani H;
    Influenza Other Respir Viruses; 2019 Jul; 13(4):339-353. PubMed ID: 30891896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.